109 related articles for article (PubMed ID: 21348912)
1. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study.
Montorsi F; Roehrborn C; Garcia-Penit J; Borre M; Roeleveld TA; Alimi JC; Gagnier P; Wilson TH
BJU Int; 2011 May; 107(9):1426-31. PubMed ID: 21348912
[TBL] [Abstract][Full Text] [Related]
2. Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Filson CP; Wei JT; Hollingsworth JM
Urology; 2013 Dec; 82(6):1386-92. PubMed ID: 24269224
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Nazir J; Heemstra L; van Engen A; Hakimi Z; Ivanescu C
BMC Urol; 2015 May; 15():41. PubMed ID: 25956727
[TBL] [Abstract][Full Text] [Related]
4. Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Fiev DN; Vinarov AZ; Tsarichenko DG; Kopylov PY; Demidko YL; Syrkin AL; Rapoport LM; Alyaev YG; Glybochko PV
Adv Ther; 2019 Aug; 36(8):2072-2085. PubMed ID: 31148056
[TBL] [Abstract][Full Text] [Related]
5. Silodosin in the treatment of benign prostatic hyperplasia.
Rossi M; Roumeguère T
Drug Des Devel Ther; 2010 Oct; 4():291-7. PubMed ID: 21116335
[TBL] [Abstract][Full Text] [Related]
6. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology.
Bird ST; Delaney JA; Brophy JM; Etminan M; Skeldon SC; Hartzema AG
BMJ; 2013 Nov; 347():f6320. PubMed ID: 24192967
[TBL] [Abstract][Full Text] [Related]
7. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms.
Schwinn DA; Roehrborn CG
Int J Urol; 2008 Mar; 15(3):193-9. PubMed ID: 18304211
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada.
Sayani A; Ismaila A; Walker A; Posnett J; Laroche B; Nickel JC; Su Z
Can Urol Assoc J; 2014; 8(1-2):E1-7. PubMed ID: 24454593
[TBL] [Abstract][Full Text] [Related]
9. [Hepatotoxicity by tamsulosin / dutasteride: report of a probable case].
Yance S; Montes P
Rev Gastroenterol Peru; 2023; 43(3):269-272. PubMed ID: 37890853
[TBL] [Abstract][Full Text] [Related]
10. Dutasteride/tamsulosin: in benign prostatic hyperplasia.
Keating GM
Drugs Aging; 2012 May; 29(5):405-19. PubMed ID: 22550968
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naïve men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results.
Roehrborn CG; Oyarzabal Perez I; Roos EP; Calomfirescu N; Brotherton B; Wang F; Palacios JM; Vasylyev A; Manyak MJ
BJU Int; 2015 Sep; 116(3):450-9. PubMed ID: 25565364
[TBL] [Abstract][Full Text] [Related]
12. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
13. Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study.
Oelke M; Roehrborn CG; D'Ancona C; Wilson TH; Castro R; Manyak M
World J Urol; 2014 Oct; 32(5):1133-40. PubMed ID: 24804842
[TBL] [Abstract][Full Text] [Related]
14. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
15. The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study.
Haillot O; Fraga A; Maciukiewicz P; Pushkar D; Tammela T; Höfner K; Chantada V; Gagnier P; Morrill B
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):302-6. PubMed ID: 21502969
[TBL] [Abstract][Full Text] [Related]
16. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014).
Oelke M; Becher K; Castro-Diaz D; Chartier-Kastler E; Kirby M; Wagg A; Wehling M
Age Ageing; 2015 Sep; 44(5):745-55. PubMed ID: 26104505
[TBL] [Abstract][Full Text] [Related]
17. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the combination of avodart and tamsulosin (CombAT) study.
Woo H
BJU Int; 2011 May; 107(9):1431. PubMed ID: 21518231
[No Abstract] [Full Text] [Related]
18. Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia.
Dimitropoulos K; Gravas S
Ther Adv Urol; 2016 Feb; 8(1):19-28. PubMed ID: 26834837
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial.
Roehrborn CG; Wilson TH; Black LK
J Urol; 2012 May; 187(5):1732-8. PubMed ID: 22425127
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
Chung BH; Lee SH; Roehrborn CG; Siami PF; Major-Walker K; Wilson TH; Montorsi F;
Int J Urol; 2012 Nov; 19(11):1031-5. PubMed ID: 22774774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
